Dirhenium(III) Carboxylate compounds as potential metallopharmaceuticals.
Poster Number
14
Format
Poster Presentation
Abstract/Artist Statement
Dinuclear carboxylate compounds have shown significant anticancer activity. In particular, dinuclear Re(ITI) species are less toxic and have greater activity than other dinuclear metal systems. This srudy focuses on the reactivity of the dirhenium core with DNA derivatives. Spectroscopic characterization of the products will be discussed.
Location
DeRosa University Center
Start Date
1-5-2001 9:00 AM
End Date
1-5-2001 5:00 PM
Dirhenium(III) Carboxylate compounds as potential metallopharmaceuticals.
DeRosa University Center
Dinuclear carboxylate compounds have shown significant anticancer activity. In particular, dinuclear Re(ITI) species are less toxic and have greater activity than other dinuclear metal systems. This srudy focuses on the reactivity of the dirhenium core with DNA derivatives. Spectroscopic characterization of the products will be discussed.